Role of Mir-33A, Mir-203B, Mir361-3P, and Mir-424 in Hepatocellular Carcinoma
Total Page:16
File Type:pdf, Size:1020Kb
Turkish Journal of Medical Sciences Turk J Med Sci (2021) 51: 638-643 http://journals.tubitak.gov.tr/medical/ © TÜBİTAK Research Article doi:10.3906/sag-2004-214 Role of mir-33a, mir-203b, mir361-3p, and mir-424 in hepatocellular carcinoma 1,2, 3 4 2,5 Burhanettin YALÇINKAYA *,Esra GÜZEL TANOĞLU , Didem TAŞTEKİN , Sadrettin PENÇE 1 Scientific and Technological Research Council of Turkey (TÜBİTAK) National Metrology Institute (UME), Kocaeli, Turkey 2 Aziz Sancar Institute of Experimental Medicine, İstanbul University, İstanbul, Turkey 3 Institute of Health Sciences, University of Health Sciences, İstanbul, Turkey 4 Institute of Oncology, İstanbul University, İstanbul, Turkey 5 Department of Physiology, Faculty of Medicine, İstanbul Medeniyet University, İstanbul, Turkey Received: 19.04.2020 Accepted/Published Online: 24.10.2020 Final Version: 30.04.2021 Background/aim: Hepatocellular carcinoma (HCC) is one of the most aggressive cancer types. MicroRNAs (miRNAs) are small noncoding regulatory RNAs that function posttranscriptionally. miRNA deregulation was observed in the development and progression of HCC. In this study, we aimed to investigate the expression levels of four miRNAs (mir-33a, mir-203b, mir361-3p, and mir-424) in HCC patients in comparison to healthy individuals. Materials and methods: Venous blood samples were collected from both HCC patients and healthy individuals. In order to determine the relative expression levels of mir-33a, mir-203b, mir361-3p, and hsa-mir-424 in HCC patients, probe-based quantitative real time PCR (qRT-PCR) was performed. The cycle threshold (Ct) results were analyzed according to the −∆∆Ct2 method and statistical analyses were performed by SPSS Statistics version 15 for Windows. Results: qRT-PCR analysis revealed that the expression levels of mir-33a (fold change: 7.3 and P < 0.001), mir-203b (fold change: 4.6 and P < 0.001), and mir361-3p (fold change: 5.1 and P < 0.001)were downregulated compared to healthy individuals and mir-424 did not show any significant change between HCC patients and controls. Conclusion: Our results indicated that mir-33a, mir-203b, and mir-361-3p may significantly contribute to tumor pathogenesis in HCC and have potential to be used as a noninvasive biomarker for cancer therapy. Key words: Mir-33a, mir-203b, mir361-3p, mir-424, HCC, qRT-PCR 1. Introduction of carcinogenesis. Numerous studies have shown that HCCis the leading cause of cancer-related deaths circulating miRNAs have clinical importance as diagnostic worldwide. It is caused by hepatocytes and it is one of the and prognostic biomarkers in HCC [5–7]. most frequently diagnosed types of primary liver cancer, mir-33a is a highly conserved member of mir-33, constituting 80%–90% of primary liver tumors [1,2]. which is located in the intronic region. It plays a role in Infection with chronic viral hepatitis B and hepatitis C is lipid metabolism and provides glucose and cholesterol the leading etiological factor for developing HCC. It has regulation. miR-33a has been shown to have growth, many different risk factors including hereditary, exposure apoptosis, epithelial-mesenchymal transition, and tumor to chemical agents such as aflatoxin B1, smoking, and suppressor effects on cancer cells [8]. chronic alcohol abuse [3]. miRNAs are single-stranded, mir-203 serves as a tumor suppressor in many types small noncoding post transcriptional regulator RNAs that of cancer including hepatocellular carcinoma, prostate, are comprised of ~20 nucleotides and have an important esophageal cancers, and breast cancer. miR-203 has been role cancer progression [4]. reported to play an important role in the carcinogenesis The analysis of miRNA expression levels in blood and progression of HCC, and there are also studies provides critical information about the prognosis of the suggesting that miR-203 may be a prognostic factor in diseasessuch as cancer and monitoring of treatment. HCC [9,10]. The analysis of tissue-specific miRNA expression level The effects of miR‐361‐3p on proliferation, invasion, can both detect tumor origin and allow early diagnosis migration, and colony formation have been reported. * Correspondence: [email protected] 638 This work is licensed under a Creative Commons Attribution 4.0 International License. YALÇINKAYA et al. / Turk J Med Sci A study has indicated that mir-361-3p, which has been 2.3. Reverse transcription and real time quantification of shown to play an active role in body fluids, decreases the miRNA expression levels of expression in prostate secretion in prostate cancer From each sample of HCC patients and healthy patients[11]. individuals, 20 ng of total RNA was reverse‐transcribed to mir-424, which has been found to have decreased cDNA using specific miRNA TaqMan Assays and TaqMan expression in many cancer types, has been reported to MicroRNA Reverse Transcription Kit (Cat no: 4366596, play a role as tumor suppressor. It has been found to Thermo Fisher Scientific) according to the manufacturer’s induce cell migration and play an important role in cancer protocol[12]. TaqMan MicroRNA Assays hsa‐miR‐33a, development and progression in HCC [5]. hsa‐miR-203b, hsa‐miR-361-3p, hsa‐miR-424, and In the literature, the expression levels of mir-33a, mir- RNU6B (Cat No: PN4427975) were obtained from Applied 203b, mir361-3p, and mir-424 have been reported to be Biosystems Thermo Fisher Scientific. RNU6B was used for either increased or decreased in various malignancies. A endogenous control of miRNA expression analyses. limited number of studies have reported these circulating The relative expression levels of miR‐33a, miR-203b, miRNAs in cancer types. miR-361-3p, and miR-424 were evaluated with qRT‐ The current study examined for the first time the PCR using TaqMan Universal PCR Master Mix (Cat no: expression levels of mir-33a, mir-203b, mir361-3p, and 4364338, Thermo Fisher Scientific) with LightCycler 480 mir-424 of peripheral blood serum in order to determine (Roche Applied Science, Penzberg, Germany). the potential biomarkers for early diagnosis, treatment, and The RT‐qPCR was performed as follows: 1 cycle of prognosis in HCC. 95 °C for 5 min, followed by 40 cycles of 95 °C for 10 s, 2. Materials and methods 60 °C for 20 s, and 72 °C for 25 s. All the samples were 2.1. Sample collection run in duplicate. The relative quantification analysis was Venous blood samples were collected from 34 patients who performed by the delta‐delta‐Ct method as described were admitted to the Gastroenterology Outpatient Clinicin previously [13,14]. Haydarpaşa Numune Training and Research Hospital of 2.4. Statistical analysis the University of Health Sciences and İstanbul University All the data were analyzed using SPSS Statistics version Oncology Institute. They had been newly diagnosed with HCC and the patients who agreed to participate in the study 15 for Windows. Two-sided Student’s t-test was used to were over the age of 18. The patients who were not included determine the significance of the difference between in the study were those who had received radiotherapy the expression levels of the analyzed microRNAs. The and chemotherapy,thecases with confirmed infection and threshold P value <0.05 was considered of statistical chronic inflammatory diseases as well as those with tumors significance [13].Online tools were used for analyzing in another organ, and those who used antibiotics and the power of the microRNAs in distinguishing HCC antiinflammatory drugs and corticosteroids. patients from healthy individuals and receiver operating As the control group, blood samples were obtained characteristic (ROC) curves plotted [15]. from healthy individuals who were not related to any type of cancer. All venous blood samples were centrifuged at 3. Results 3000 rpm for 10 min and the extracted serum samples were Table 1 presents the epidemiologic variables and clinical stored in a freezer at −80 °C. data of HCC patients and healthy individuals. Drinking status, smoking status, and family history The mean female patient age was 51 ± 9 and 29% and of cancer were recorded according to the declarations of 41% of the healthy individuals were female with a mean patients and healthy individuals. The presence of chronic age of 48 ± 10 years. More patients had a family history hepatitis B and C and cirrhosis was recorded according to of cancer than healthy individuals (P < 0.05), which was laboratory and radiological test results. All epidemiologic determined as 32% and 12%, respectively. variables and clinical data were collected by physicians In patients, 24% were ever smoker and 21% of them (Table 1). were ever drinker. In healthy individuals, 32% were ever 2.2. RNA isolation smoker and 12% of them were ever drinker. As expected, RNAs were isolated from 500 µL fresh serum samples with most of the patients (71%) had cirrhosis and 41% had a mirVana™ miRNA Isolation Kit (Thermo Fisher Scientific, chronic hepatitis B, and 32% had chronic hepatitis C. None Waltham, MA, USA; Catalog No AM1560) according to the of the healthy individuals had chronic hepatitis B or C; manufacturer’s protocol. The concentration and purity of also, none of them had cirrhosis. There was no significant the isolated RNAs were measured at 230, 260, and 280 nm difference between patients and healthy individuals in with a NanoDrop Spectrophotometer (ND-1000 Thermo terms of sex, age, smoking, and drinking status (all P > Fisher Scientific). 0.05). 639 YALÇINKAYA et al. / Turk J Med Sci Table 1. Epidemiologic variables and clinical